Dace V. Madore

5.3k total citations · 1 hit paper
47 papers, 4.3k citations indexed

About

Dace V. Madore is a scholar working on Epidemiology, Microbiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dace V. Madore has authored 47 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 32 papers in Microbiology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dace V. Madore's work include Pneumonia and Respiratory Infections (42 papers), Bacterial Infections and Vaccines (32 papers) and Respiratory viral infections research (22 papers). Dace V. Madore is often cited by papers focused on Pneumonia and Respiratory Infections (42 papers), Bacterial Infections and Vaccines (32 papers) and Respiratory viral infections research (22 papers). Dace V. Madore collaborates with scholars based in United States, Estonia and Denmark. Dace V. Madore's co-authors include Ih Chang, George R. Siber, Frank Malinoski, Jill Hackell, Henry R. Shinefield, Steven Black, Robert Kohberger, Paula Ray, Bruce Fireman and John Hansen and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Dace V. Madore

47 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

2000 1.8k citations Steven Black, Henry R. Shinefield et al. The Pediatric Infectious Disease Journal profile →

Peers

Countries citing papers authored by Dace V. Madore

Since Specialization

Citations

This map shows the geographic impact of Dace V. Madore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dace V. Madore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dace V. Madore more than expected).

Fields of papers citing papers by Dace V. Madore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dace V. Madore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dace V. Madore. The network helps show where Dace V. Madore may publish in the future.

Co-authorship network of co-authors of Dace V. Madore

This figure shows the co-authorship network connecting the top 25 collaborators of Dace V. Madore. A scholar is included among the top collaborators of Dace V. Madore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dace V. Madore. Dace V. Madore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads 2010 ·Vaccine ·Dace V. Madore, Bruce D. Meade, (unknown), Carolyn Deal, Freyja Lynn	28
2	Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody 2007 ·Biologicals ·(unknown), (unknown), Jorge A. Quiroz, Dace V. Madore, Ruth Rappaport	10
3	Predictors of Pneumococcal Conjugate Vaccine Immunogenicity among Infants and Toddlers in an American Indian PnCRM7 Efficacy Trial 2007 ·The Journal of Infectious Diseases ·Katherine L. O’Brien, Jennifer C. Moïsi, Lawrence H. Moulton, Dace V. Madore, Angelia A. Eick, (unknown), Robert Weatherholtz, Eugene V. Millar, Diana Hu, Jill Hackell, Robert Kohberger, George R. Siber, Mathuram Santosham	30
4	Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine 2007 ·Clinical Infectious Diseases ·Eugene V. Millar, Katherine L. O’Brien, Melinda A. Bronsdon, Dace V. Madore, Jill Hackell, (unknown), Mathuram Santosham	56
5	Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine 2004 ·Vaccine ·Robin Huebner, Nontombi Mbelle, Bruce D. Forrest, Dace V. Madore, Keith P. Klugman	22
6	Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa 2002 ·The Pediatric Infectious Disease Journal ·Robin Huebner, Nontombi Mbelle, Bruce D. Forrest, Dace V. Madore, Keith P. Klugman	50
7	A MULTI-LABORATORY EVALUATION OF AN ENZYME-LINKED IMMUNOASSAY QUANTITATING HUMAN ANTIBODIES TOSTREPTOCOCCUS PNEUMONIAEPOLYSACCHARIDES 2001 ·Immunological Investigations ·Sally A. Quataert, Diana Martı́n, Patrick L. Anderson, G. Scott Giebink, J Henrichsen, M. Leinonen, D. M. Granoff, Harold Russell, George R. Siber, Howard Faden, (unknown), Dace V. Madore	34
8	Efficacy, Safety, and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Children 2000 ·The American Journal of Managed Care ·Steven Black, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jill Hackell, George R. Siber, Frank Malinoski, Dace V. Madore, Ih Chang, Robert Kohberger, (unknown)	3
9	Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children breakdown → 2000 ·The Pediatric Infectious Disease Journal ·Steven Black, Henry R. Shinefield, Bruce Fireman, Edwin Lewis, Paula Ray, John Hansen, (unknown), Kathleen Ensor, Jill Hackell, George R. Siber, Frank Malinoski, Dace V. Madore, Ih Chang, Robert Kohberger, Wendy Watson, Robert Austrian, Kathryn M. Edwards	1817
10	Group‐Specific Antibody Levels Surrounding Invasive Pneumococcal Illness in Children Infected with Human Immunodeficiency Virus 2000 ·The Journal of Infectious Diseases ·James C. King, William Borkowsky, (unknown), Dace V. Madore, Eugene D. Shapiro, Richard M. Rutstein, Tina Q. Tan, John Farley, Wayne M. Dankner, Sharon Nachman, Eric A. F. Simões, Patricia M. Flynn, John D. Clemens, Robert G. Hamilton	8
11	Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers 1999 ·The Pediatric Infectious Disease Journal ·Henry R. Shinefield, Steven Black, Paula Ray, Ih Chang, Ned Lewis, Bruce Fireman, Jill Hackell, Peter R. Paradiso, George R. Siber, Robert Kohberger, Dace V. Madore, (unknown), Alan Kimura, Chinh T. Lé, (unknown), (unknown), John Hansen	234
12	Kinetics of Antibody Response to Haemophilus influenzae Type b Vaccines 1999 ·Current Medical Research and Opinion ·Dace V. Madore, (unknown), Edward Rothstein, David H. Smith	16
13	Use of Highly Encapsulated Streptococcus pneumoniae Strains in a Flow-Cytometric Assay for Assessment of the Phagocytic Capacity of Serotype-Specific Antibodies 1998 ·Clinical and Diagnostic Laboratory Immunology ·Wim Jansen, (unknown), M. R. Zelle, Dace V. Madore, J. Verhoef, H. Snippe, A F Verheul	39
14	Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children 1996 ·The Pediatric Infectious Disease Journal ·James C. King, Peter Vink, John Farley, (unknown), (unknown), Dace V. Madore, Richard Lichenstein, Frank Malinoski	69
15	Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines 1996 ·The Pediatric Infectious Disease Journal ·Katherine L. O’Brien, M. C. Steinhoff, Kathryn M. Edwards, Harry Keyserling, M. L. Thoms, Dace V. Madore	87
16	Mechanism of Antibody-Mediated Reduction of Nasopharyngeal Colonization by Haemophilus influenzae Type b Studied in an Infant Rat Model 1996 ·The Journal of Infectious Diseases ·(unknown), L van Alphen, Dace V. Madore, Leena Saarinen, Helena Käyhty	25
17	Progress and Challenges for a New Combination Vaccine Composed of Diphtheria, Tetanus, Acellular Pertussis, and Haemophilus b Conjugate 1995 ·Annals of the New York Academy of Sciences ·Dace V. Madore	1
18	Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy 1993 ·The Pediatric Infectious Disease Journal ·Steven Black, Henry R. Shinefield, Paula Ray, Edwin Lewis, Bruce Fireman, Robert A. Hiatt, Dace V. Madore, Cynthia Johnson, Jill Hackell	19
19	Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine 1991 ·The Journal of Pediatrics ·Edward Rothstein, Dace V. Madore, Sarah S. Long	18
20	An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay 1990 ·Journal of Immunological Methods ·D C Phipps, (unknown), (unknown), (unknown), Dace V. Madore, Sally A. Quataert	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact